Armistice Capital, LLC 13D and 13G filings for Alto Neuroscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-18 4:46 pm Sale | 2025-12-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Armistice Capital, LLC | 1,536,000 4.940% | -88,000 (-5.42%) | Filing |
| 2025-08-14 9:37 pm Sale | 2025-06-30 | 13G | ALTO NEUROSCIENCE INC ANRO | Armistice Capital, LLC | 1,996,000 7.050% | -664,745 (-24.98%) | Filing |
| 2025-05-15 3:05 pm Purchase | 2025-03-31 | 13G | ALTO NEUROSCIENCE INC ANRO | Armistice Capital, LLC | 1,600,000 5.910% | 1,600,000 (New Position) | Filing |